We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Reliv International Inc | NASDAQ:RELV | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.68 | 3.30 | 3.68 | 0 | 00:00:00 |
CHESTERFIELD, Mo,, May 15, 2020 /PRNewswire/ -- Reliv International, Inc. (NASDAQ:RELV), a developer and marketer of nutritional supplements that promote optimal health, today reported its financial results for the first quarter of 2020.
First-Quarter Results
Reliv reported net sales of $10.3 million for the first quarter of 2020 compared with net sales of $9.5 million in the first quarter of 2019. Net sales in the United States increased to $7.8 million in the first quarter of 2019, which represented a 10.3% increase in net sales when compared to the prior-year quarter. Net sales in Reliv's foreign markets increased 2.6% in the first quarter of 2020 compared with the prior-year first quarter. Increases in net sales in Asia and Europe were 10.1% and 2.4%, respectively, in the first quarter of 2020, offset by decreases in net sales in other regions.
Reliv reported net income for the first quarter of 2020 of $662,000 (earnings per diluted share of $0.38) compared to net income of $624,000 (earnings per diluted share of $0.36) in the first quarter of 2019. The income from operations for the first quarter of 2020 was $522,000 compared to $199,000 in the same period in 2019. Results from operations in 2020 were favorably impacted by the improvement in net sales and resulting gross margin in the United States and most of Reliv's foreign markets. Reliv also recognized an income tax benefit of $178,000 in the first quarter of 2020. This benefit was the result of the Coronavirus Aid, Relief, and Economic Security (CARES) Act which was signed into law in late March 2020. Under the CARES Act, the U.S. net operating loss (NOL) arising in our 2018 tax year may be carried back up to five years. Based on this new legislation, we have recognized a $225,000 estimated income tax benefit for the NOL carryback.
Reliv had cash and cash equivalents of $2.8 million as of March 31, 2020, compared to $1.6 million as of December 31, 2019. Net cash provided by operating activities was $1.3 million in the first quarter of 2020.
As of March 31, 2020, Reliv had 13,680 retail customers and Preferred Customers in total – a decrease of 6.9% from March 31, 2019. This count does not include those customers that buy product directly from distributors rather than from us. As of March 31, 2020, Reliv had 25,550 active Distributors – an increase of 1.0% from March 31, 2019. The number of Master Affiliates increased by 7.7% compared to the year-ago total, driven by the growth in Master Affiliates in Asia of 74.3%. Master Affiliate is the level at which Distributors are eligible to earn generation royalties.
"We were pleased with our performance in the first quarter," commented Ryan A. Montgomery, Chief Executive Officer. "It showed the strength of consumer demand for our products, but we recognize a portion of the increase may be due to product supply concerns caused by these uncertain times. We have reassured customers of the continued supply of our products, and in an effort to continue the upward trend in consumer sales, we began offering free enrollments in our Preferred Customer program in April and are continuing this incentive during the month of May."
"To improve our outreach, we have substantially increased our use of online technology as our primary method of communication and training with our customers and distributors as we adapt to the realities of the world today," Montgomery noted. Reliv recently announced that its U.S. distributor conference originally planned to be held in St. Louis in late July will instead be a world-wide online conference. "We felt this was the right decision to make well in advance of the scheduled conference date. We are excited by the opportunity of reaching out to a much larger audience, not only in the United States, but all over the Reliv world."
Prior to the COVID-19 outbreak, Reliv held a successful distributor conference in Dallas in mid-February where the company introduced its latest offering in the RLV line of hemp-extract products—a sleep-aid tincture that includes melatonin.
In international operations, net sales in the Philippines and Europe grew in the first quarter in spite of earlier and more restrictive COVID-19 guidelines than experienced in most of the United States. Net sales in Asia and Europe grew by 10.1% and 2.4%, respectively, in the first quarter of 2020, compared to the prior-year quarter. Montgomery commented, "We are pleased by the resilience of the sales in these regions; however, we are cautious in our plans with the uncertainty of the long-term impact of the pandemic in various parts of the Reliv world."
About Reliv International, Inc.
Reliv International, based in Chesterfield, MO, develops and markets nutritional supplements that promote optimal nutrition. Reliv supplements address core nutrition, targeted solutions and overall wellness and now include a line of RLV hemp extracts. Reliv is the exclusive provider of LunaRich® products, which optimize levels of lunasin, a soy peptide that works at the epigenetic level to promote optimal health. The company sells its products through an international network marketing system of independent distributors in 13 countries. Learn more about Reliv at reliv.com, or on Facebook, Twitter or Instagram.
Statements made in this news release that are not historical facts are "forward-looking" statements (as defined in the Private Securities Litigation Reform Act of 1995) that involve risks and uncertainties and are subject to change at any time. These forward-looking statements may include, but are not limited to, statements containing words such as "may," "should," "could," "would," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential," "continue" or similar expressions. Factors that could cause actual results to differ are identified in the public filings made by Reliv with the Securities and Exchange Commission. More information on factors that could affect Reliv's business and financial results are included in its public filings made with the Securities and Exchange Commission, including its Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, copies of which are available on the Company's web site, reliv.com.
For more information, contact:
Steve Albright
Chief Financial Officer
(636) 733-1305
--FINANCIAL HIGHLIGHTS FOLLOW –
Reliv International, Inc. and Subsidiaries | ||
Condensed Consolidated Balance Sheets | ||
March 31 | December 31 | |
2020 | 2019 | |
(Unaudited) | (Audited) | |
Assets | ||
Current Assets: | ||
Cash and cash equivalents | $2,828,639 | $1,630,779 |
Accounts receivable, less allowances of | ||
$5,000 in 2020 and 2019 | 215,045 | 107,369 |
Notes & accounts receivables & deposits - related parties | 1,091,247 | 1,099,228 |
Inventories | 2,809,829 | 2,701,688 |
Other current assets | 909,038 | 326,454 |
Total current assets | 7,853,798 | 5,865,518 |
Notes & accounts receivables - related parties | 2,390,930 | 2,418,921 |
Other assets | 2,436,718 | 2,581,717 |
Net property, plant and equipment | 4,359,436 | 4,440,840 |
Total Assets | $17,040,882 | $15,306,996 |
Liabilities and Stockholders' Equity | ||
Accounts payable, accruals & other current liabilities | $4,624,415 | $3,489,157 |
Revolving line of credit | 500,000 | 500,000 |
Other noncurrent liabilities | 192,099 | 216,196 |
Stockholders' equity | 11,724,368 | 11,101,643 |
Total Liabilities and Stockholders' Equity | $17,040,882 | $15,306,996 |
Consolidated Statements of Operations | ||
Three months ended March 31 | ||
2020 | 2019 | |
(Unaudited) | (Unaudited) | |
Product sales | $9,548,817 | $8,810,997 |
Freight income | 558,095 | 519,941 |
Other revenue | 175,753 | 158,566 |
Net Sales | 10,282,665 | 9,489,504 |
Costs and expenses: | ||
Cost of goods sold | 2,654,843 | 2,433,732 |
Distributor royalties and commissions | 3,328,455 | 3,117,572 |
Selling, general and administrative | 3,777,682 | 3,739,527 |
Total Costs and Expenses | 9,760,980 | 9,290,831 |
Income from operations | 521,685 | 198,673 |
Other income (expense): | ||
Interest income | 39,662 | 49,262 |
Interest expense | (6,105) | (5,412) |
Other expense | (70,906) | (5,428) |
Gain on sale of fixed assets | - | 434,549 |
Income before income taxes | 484,336 | 671,644 |
Provision (benefit) for income taxes | (178,000) | 48,000 |
Net income | $662,336 | $623,644 |
Earnings per common share - Basic & Diluted | $0.38 | $0.36 |
Weighted average shares | 1,746,000 | 1,746,000 |
Reliv International, Inc. and Subsidiaries | ||||||||
Net sales by Market | ||||||||
(in thousands) | Three months ended March 31, | Change from | ||||||
2020 | 2019 | prior year | ||||||
Amount | % of Net | Amount | % of Net | Amount | % | |||
United States | $ 7,842 | 76.3% | $ 7,112 | 74.9% | $ 730 | 10.3% | ||
Australia/New Zealand | 170 | 1.6% | 177 | 1.9% | (7) | -4.0% | ||
Canada | 159 | 1.5% | 199 | 2.1% | (40) | -20.1% | ||
Mexico | 129 | 1.3% | 136 | 1.4% | (7) | -5.1% | ||
Europe | 962 | 9.4% | 939 | 9.9% | 23 | 2.4% | ||
Asia | 1,021 | 9.9% | 927 | 9.8% | 94 | 10.1% | ||
Consolidated Total | $ 10,283 | 100.0% | $ 9,490 | 100.0% | $ 793 | 8.4% |
The tables below set forth, as of March 31, 2020 and 2019, the number of our Retail Customers/Preferred Customers/Active Distributors and Master Affiliates and above. The total number of active distributors includes Master Affiliates and above. We define an active retail or preferred customer as one that has placed a product order in the prior twelve months, and we define an active distributor as one that enrolls as a distributor or renews his or her distributorship during the prior twelve months. Many individuals join Reliv as distributors to obtain our products at a discount and may not participate in the Reliv business opportunity. Master Affiliates and above are distributors that have attained the highest level of discount and are eligible for royalties generated by Master Affiliate groups in their downline organization.
Reliv International, Inc. and Subsidiaries | |||||
Retail and Preferred Customers/Active Distributors/Master Affiliates and Above by Market | |||||
As of 3/31/2020 | |||||
Retail | Preferred | Active | Total | Master | |
United States | 3,580 | 1,450 | 17,460 | 22,490 | 1,860 |
Australia/New Zealand | 50 | 210 | 650 | 910 | 80 |
Canada | 80 | 30 | 470 | 580 | 60 |
Mexico | 20 | 100 | 1,050 | 1,170 | 80 |
Europe | 690 | 660 | 1,620 | 2,970 | 260 |
Asia | 1,370 | 5,440 | 4,300 | 11,110 | 610 |
Consolidated Total | 5,790 | 7,890 | 25,550 | 39,230 | 2,950 |
Reliv International, Inc. and Subsidiaries | |||||
Retail and Preferred Customers/Active Distributors/Master Affiliates and Above by Market | |||||
(continued) | |||||
As of 3/31/2019 | |||||
Retail | Preferred | Active | Total | Master | |
United States | 3,960 | 1,560 | 18,040 | 23,560 | 1,880 |
Australia/New Zealand | 40 | 220 | 710 | 970 | 70 |
Canada | 100 | 20 | 520 | 640 | 60 |
Mexico | 10 | 110 | 1,020 | 1,140 | 80 |
Europe | 560 | 1,140 | 1,800 | 3,500 | 300 |
Asia | 3,020 | 3,950 | 3,210 | 10,180 | 350 |
Consolidated Total | 7,690 | 7,000 | 25,300 | 39,990 | 2,740 |
Change in % | |||||
Retail | Preferred | Active | Total | Master | |
United States | -9.6% | -7.1% | -3.2% | -4.5% | -1.1% |
Australia/New Zealand | 25.0% | -4.5% | -8.5% | -6.2% | 14.3% |
Canada | -20.0% | 50.0% | -9.6% | -9.4% | 0.0% |
Mexico | 100.0% | -9.1% | 2.9% | 2.6% | 0.0% |
Europe | 23.2% | -42.1% | -10.0% | -15.1% | -13.3% |
Asia | -54.6% | 37.7% | 34.0% | 9.1% | 74.3% |
Consolidated Total | -24.7% | 12.7% | 1.0% | -1.9% | 7.7% |
View original content to download multimedia:http://www.prnewswire.com/news-releases/reliv-international-reports-first-quarter-financial-results-for-2020-301059829.html
SOURCE Reliv International
Copyright 2020 PR Newswire
1 Year Reliv Chart |
1 Month Reliv Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions